FDA Inspection 1041324 — Profil Mainz GmbH & Co. KG
The FDA completed an inspection of Profil Mainz GmbH & Co. KG on Jan 16, 2018 in Mainz. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 16, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Mainz (Germany)
Additional Details
Clinical BA/BE